Read Rosen & Barkin's 5-Minute Emergency Medicine Consult Online

Authors: Jeffrey J. Schaider,Adam Z. Barkin,Roger M. Barkin,Philip Shayne,Richard E. Wolfe,Stephen R. Hayden,Peter Rosen

Tags: #Medical, #Emergency Medicine

Rosen & Barkin's 5-Minute Emergency Medicine Consult (481 page)

BOOK: Rosen & Barkin's 5-Minute Emergency Medicine Consult
5.31Mb size Format: txt, pdf, ePub
ads
DESCRIPTION
  • Acute glomerulonephritis (AGN) is acute inflammatory damage to glomerulus, associated with:
    • Abrupt onset of hematuria with or without RBC casts
    • Acute renal failure manifested by edema, hypertension, azotemia, decline in urine output
    • Variable proteinuria
    • Active urine sediment (RBC casts)
  • Exact mechanism of AGN unclear:
    • Combination of autoimmune reactivity to specific antigens at renal glomeruli
    • Characterized by crescent formation secondary to nonspecific injury at the glomerular wall
ETIOLOGY
  • Poststreptococcal glomerulonephritis (PSGN):
    • A postinfectious cause of acute nephritic syndrome, resulting from group A β-hemolytic streptococci
    • Considered a nonsuppurative complication (antibiotic treatment does not prevent this complication)
    • Occurs when immune complexes create hump-shaped subepithelial deposits in renal glomeruli
    • Most commonly affects patients between ages 3 and 15 yr but can occur at any age
    • Incidence of nephritis is 5–10% after pharyngitis and 25% after skin infections.
    • Consider PSGN in the setting of new-onset proteinuria, RBC casts, edema, and any recent infection.
    • Latent period between infection and onset of nephritis helps differentiate between PSGN and IgA nephropathy:
      • 1–3 wk in pharyngeal infection
      • 2–4 wk in cutaneous infection
    • Renal biopsy is usually not necessary for diagnosis.
    • Low complement (C3) for 6–8 wk
    • Can progress to severe renal failure if underlying infection goes untreated
    • Prognosis:
      • Excellent; >95% recover spontaneously with normalization of renal function within 6–8 wk, even with dialysis.
      • Hematuria usually resolves in 3–6 mo.
      • Transient nephrotic phase in 20% of patients during resolution of illness
      • End-stage renal disease occurs <5%
      • Rapidly progressive glomerulonephritis (RPGN) is rare, occurring in <1% cases.
      • Most cases resolve spontaneously with no long-term sequelae.
  • Other infectious sources of glomerulonephritis (GN):
    • Sepsis, pneumonia, endocarditis, viruses, HIV
    • Pulmonary, intra-abdominal, or cutaneous infections
    • Syphilis, leprosy, schistosomiasis, and malaria
    • Goal: Treat underlying infection.
  • Hepatitis virus–related glomerular disease:
    • Can present with either nephritic or nephrotic symptoms
    • Causes membranoproliferative GN
    • Complements remain low indefinitely (compared to PSGN)
  • Noninfectious causes of GN (due to immune complex formation):
    • Systematic lupus erythematosus, Henoch–Schönlein purpura, vasculitis, Wegener granulomatosis
    • Goodpasture syndrome
  • IgA nephropathy (IgA-N)
    • Most common cause of AGN (>25%) worldwide
    • Antibody–antigen causes immune complex deposition of IgA and C3
    • Complement levels are usually normal.
    • IgA-N has different presentations:
      • Gross hematuria following upper respiratory infection (URI)
      • Microscopic hematuria with proteinuria
      • Hematuria during viral illness or after exercise
      • Prognosis is related to serum creatinine, BP, and proteinuria.
      • 50% of patients with proteinuria may develop progressive renal disease.
      • ACE inhibitors or angiotensin-receptor blockers (ARBs) may help
  • RPGN:
    • Certain patients with AGN may progress rapidly to renal failure.
    • Hallmarks are crescents on renal biopsy.
  • Hereditary nephritis
    • Alport syndrome
DIAGNOSIS
SIGNS AND SYMPTOMS
  • Hematuria:
    • Abrupt onset gross hematuria in 30–40% (coffee- or cola-colored urine)
  • Edema:
    • Periorbital edema
    • Generalized edema more common in infants and children
  • Infectious source or recent infection: Upper respiratory tract or skin common, e.g., PSGN
  • Symptoms of congestive heart failure:
    • 40% occurrence in patients >60 yr
    • Rare in children
  • Arthritis, arthralgias, and various skin rashes: PSGN, systemic disease
  • Nonspecific manifestations:
    • Malaise
    • Weakness
    • Anorexia
    • Nausea/vomiting
History
  • Recent URI or skin or other infection
  • Change in urine color
Physical-Exam
  • Hypertension
  • Edema
ESSENTIAL WORKUP

Urinalysis with sediment evaluation to detect:

  • RBCs, proteinuria, and RBC casts
  • RBC casts are diagnostic of an active glomerular inflammation.
DIAGNOSIS TESTS & NTERPRETATION
Lab
  • CBC:
    • Anemia (seen in more chronic cases of GN or other systemic disease)
    • Acute leukocytosis (may suggest infectious process)
  • Basic metabolic panel:
    • Assess baseline renal function
    • Check for electrolyte abnormalities
    • GFR will be normal or nearly normal
  • Urinalysis:
    • RBCs +/− casts, protein
  • Serum albumin
  • Cultures (throat, skin, urine, blood):
    • As clinically suspected for infectious source
    • Streptozyme
  • Serum complement level (C3): Decreased in infectious endocarditis, shunt nephritis, and PSGN
  • Streptococcal antibodies:
    • Antistreptolysin (ASO), antistreptokinase (ASK), antideoxyribonuclease B (ADNase B), antinicotinyl adenine dinucleotidase (ANADase), and antihyaluronidase (AH)
    • ASO more reactive in pharyngeal infections
    • ADNase B, ANADase, and AH more reactive in cutaneous infections
    • ASK elevated in recent hemolytic Streptococcus infections
    • Titers do not correlate with prognosis of disease
  • Urine osmolality, sodium, creatinine
  • 24-hr urine collection:
    • Proteinuria initially present in 5% of children, 20% of adults with PSGN
Imaging
  • Renal ultrasound: Kidney size abnormality
  • Chest radiograph: Cardiomegaly, pulmonary edema, infection
Diagnostic Procedures/Surgery

Renal biopsy:

  • Generally not done for PSGN, as symptoms typically resolve after a brief illness
  • Recommended if atypical features of PSGN, persistently abnormal complement levels, persistent hypertension, and proteinuria >3 g/d
  • Facilitates diagnosis for other causes of nephritis
DIFFERENTIAL DIAGNOSIS
  • (See “Glomerulonephritis” for further information on types of GN)
  • Renal:
    • Primary glomerular disease
  • Systemic:
    • Goodpasture syndrome
    • Vasculitis
    • Henoch–Schönlein purpura
  • Other (rare):
    • Hemolytic-uremic syndrome
    • Thrombotic thrombocytopenic purpura
    • Acute hypersensitivity interstitial nephritis
    • Serum sickness
TREATMENT
PRE HOSPITAL

Support ABCs

INITIAL STABILIZATION/THERAPY

ABCs

ED TREATMENT/PROCEDURES
  • Antibiotics for streptococcal infection:
    • Penicillin (erythromycin, if penicillin allergic)
  • Restrict salt and fluid intake
  • Administer loop diuretics (furosemide)
  • Restore urine flow in oliguric patients:
    • Mannitol
  • Treat pulmonary edema:
    • Oxygen
    • Morphine
    • Loop diuretics
  • Stabilize BP to decrease proteinuria, retard progression of GN:
    • ACEIs, ARBs
    • Hypertensive emergency: Nitroprusside or other titratable antihypertensive medication
  • Hemodialysis for:
    • Severe hyperkalemia
    • Fluid overload
    • Uremia
    • Severe acidosis
    • Correct electrolyte abnormalities
MEDICATION
  • Erythromycin: 250–500 mg (peds: 30–50 mg/kg/d) PO q6h for 7–10 days
  • Furosemide: 20–80 mg (peds: 1–6 mg/kg) PO daily/BID
  • Lisinopril (ACEI): 10–40 mg (peds: >6 yr: 0.07 mg/kg) PO daily
  • Losartan (ARB): 25–100 mg (peds: >6 yr: 0.7 mg/kg) PO daily
  • Mannitol: 12.5–100 g (peds: 0.25–0.5 g/kg) IV:
    • May use single or repeat dosing; consider test dosing 1st.
  • Morphine sulfate: 0.1 mg/kg/dose IV q4h
  • Nitroprusside: 0.3–4 μg/kg/min IV
    • Titrate to goal mean arterial pressure for hypertensive emergency.
  • Penicillin:
    • Benzathine penicillin: 1.2 million U (peds: 0.3–0.9 million U, based on weight) IM as single dose
    • Penicillin VK: 250–500 mg (peds: <12 yr 25–50 mg/kg/d) PO q6–8h for 10 days
  • Other agents, including fish oil (ω-3 fatty acids for anti-inflammatory effects) and immunosuppressive agents (glucocorticoids, cyclophosphamide), may be used in consultation with specialists.
FOLLOW-UP
DISPOSITION
Admission Criteria
  • Evidence of infectious cause for GN
  • Oliguria, anuria
  • Uremia
  • Elevated creatinine
  • Edema
  • Electrolyte abnormalities
  • Severe hypertension
  • CHF
BOOK: Rosen & Barkin's 5-Minute Emergency Medicine Consult
5.31Mb size Format: txt, pdf, ePub
ads

Other books

Bluegrass State of Mind by Kathleen Brooks
WastelandRogue by Brenda Williamson
The Fan by Peter Abrahams
The Runaway Jury by John Grisham